LEA WHARF MEDICAL — All Prescriptions & Medications — Page 14
Practice Code: E82024 | HERTFORD, SG14 1BN
Showing results 651-700 of 716
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Heparinoid | 13 | 650 | £49 | -0.3% vs avg |
| 13 | 157 | £430 | +89.3% ▲ | |
| 13 | 96 | £104 | +25.1% ▲ | |
| 13 | 1,350 | £3.2K | -73.3% ▼ | |
| 13 | 130 | £401 | -36.1% ▼ | |
| 13 | 1,050 | £2.9K | -12.1% ▼ | |
| Sodium cromoglicate | 12 | 1,344 | £2.0K | +16.0% ▲ |
| Aclidinium bromide/formoterol | 12 | 12 | £371 | -65.9% ▼ |
| Rimegepant | 12 | 220 | £2.8K | +22.3% ▲ |
| Cenobamate | 12 | 294 | £1.8K | -50.5% ▼ |
| Itraconazole | 12 | 573 | £227 | -10.6% ▼ |
| Vildagliptin | 12 | 672 | £203 | -17.3% ▼ |
| Raloxifene hydrochloride | 12 | 84 | £12 | -18.8% ▼ |
| Bicalutamide | 12 | 420 | £26 | -62.9% ▼ |
| RtS 3.3 - 4 kcal/ml energy with protein liquid (0913141) | 12 | 46.7K | £1.4K | -54.8% ▼ |
| Tube feed 1.5 kcal/ml with fibre (0914021) | 12 | 295.0K | £8.0K | +4.7% ▲ |
| Tube feed 1 kcal/ml soya based (0914033) | 12 | 468.0K | £7.6K | +52.4% ▲ |
| Apraclonidine | 12 | 1,220 | £5.5K | -4.7% ▼ |
| Other barrier preparations | 12 | 360 | £38 | +102.8% ▲ |
| Ketoconazole | 12 | 480 | £65 | +20.6% ▲ |
| 12 | 143 | £547 | +34.9% ▲ | |
| 12 | 2,820 | £4.7K | -31.9% ▼ | |
| 12 | 290 | £344 | -42.4% ▼ | |
| 12 | 800 | £567 | -63.7% ▼ | |
| 12 | 21 | £1.0K | +169.0% ▲ | |
| 12 | 13 | £1.1K | +265.5% ▲ | |
| 12 | 430 | £1.9K | +42.2% ▲ | |
| 12 | 1,750 | £158 | -74.6% ▼ | |
| 12 | 660 | £3.5K | -6.1% ▼ | |
| Phosphates (Rectal) | 11 | 29 | £595 | -10.0% ▼ |
| Nadolol | 11 | 616 | £407 | +8.8% ▲ |
| Meptazinol hydrochloride | 11 | 980 | £185 | -66.7% ▼ |
| Nicotine | 11 | 311 | £172 | -80.5% ▼ |
| Rifaximin | 11 | 616 | £2.9K | -59.0% ▼ |
| Oestrogens conjugated | 11 | 1,344 | £506 | -46.1% ▼ |
| Tibolone | 11 | 588 | £59 | -64.1% ▼ |
| Combined ethinylestradiol 35mcg | 11 | 1,890 | £132 | -11.7% ▼ |
| Sodium chloride | 11 | 360 | £239 | -63.0% ▼ |
| 11 | 147 | £3.1K | +38.1% ▲ | |
| 11 | 160 | £587 | +171.9% ▲ | |
| 11 | 876 | £254 | -43.1% ▼ | |
| 11 | 120 | £3.2K | +98.8% ▲ | |
| 11 | 104 | £144 | -33.3% ▼ | |
| 11 | 53 | £144 | -19.0% ▼ | |
| 11 | 1,100 | £209 | -57.3% ▼ | |
| 11 | 13 | £826 | +327.7% ▲ | |
| 11 | 330 | £302 | -72.9% ▼ | |
| 11 | 1,260 | £1.6K | -32.6% ▼ | |
| Citalopram hydrochloride | 10 | 300 | £214 | -37.7% ▼ |
| Zonisamide | 10 | 2,784 | £3.3K | -77.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.